United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Technology Industry News Samsara stock jumps 15% on strong second-quarter earnings and raised guidance Samsara Inc. shares surged by 15% on Friday to $44.84, driven by a second-quarter earnings report that beat… byPallavi MadhirajuSeptember 6, 2024